IceCure Medica shares are trading higher after the company announced a 70% increase in its U.S. active commercial install base of ProSense for breast cancer cryoablation.

Benzinga Newsdesk www.benzinga.com Positive 95.5%

Neg 0% Neu 0% Pos 95.5%

Comments

No comments yet. Be the first!